In The Costly U.S. Health Care Market, Mark Cuban’s Company Has A Plan To Reduce Prescription Drug Costs

By operating transparently as a public benefit corporation, Mark Cuban Cost Plus Drug Company aims to expand affordable access to medication and help to reshape the $4.1 trillion U.S. health care industry.